EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reactivation of P53 Antiproliferative and Pro-Apoptotic Pathways by Resveratrol in Mutant P53 Cancer Cell Lines

Andrea Acosta-Dent, Enrique García-Villa, Sandra Cotino-Nájera, Solangy Lizcano-Meneses iD, Francisco Alejandro Lagunas-Rangel, Efraín Garrido-Guerrero, José Díaz-Chávez iD, Patricio Gariglio

International Journal of Molecular Sciences · 16.05.2026 · 27 (10) · 4481

DOI: 10.3390/ijms27104481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.05.2026. Verfasst von Andrea Acosta-Dent und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, …. Hauptthemen laut MEDLINE: Resveratrol, Tumor Suppressor Protein p53, Apoptosis, Cell Proliferation. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología, Mexico, Consejo Nacional de Ciencia y Tecnología, México.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is the second leading cause of death worldwide. Mutations in the TP53 gene lead to a loss of tumor suppressor function and an oncogenic gain of function for the protein, resulting in a more invasive, metastatic, and chemoresistant phenotype. Diverse structural studies have demonstrated that mutant p53 core domain unfolding is not irreversible. Thus, reactivation toward its wild-type-like conformation or inactivation of its mutant p53 capacities may restore the expression of genes in its tumor suppressor pathways, resulting in enhanced responses to current therapies. Resveratrol (3,4′,5-trihydroxy-trans-stilbene) is a phytoalexin naturally found in more than 70 plant species that has widely proven antiproliferative and pro-apoptotic properties, as well as a capacity to reverse multidrug resistance in various cancer types. Interestingly, it has recently been demonstrated that resveratrol directly interacts with the p53 core domain and reduces mutant p53 aberrant aggregation. In this context, our study aims to elucidate whether resveratrol may induce antiproliferative and pro-apoptotic pathways regardless of a mutant background. We observed that resveratrol has an antiproliferative effect in cancer cells, independent of p53 status, and leads to apoptosis after 48 h of treatment. Resveratrol also induces the expression of p53 tumor suppressor target genes, which are involved in cell cycle arrest and apoptosis. Even though the previous effects are more significant in cells expressing wild-type p53, resveratrol drastically sensitizes all cancer cell lines, regardless of p53 status, to cisplatin treatment, making it a promising enhancer compound to overcome chemoresistance associated with p53.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResveratrolTumor Suppressor Protein p53ApoptosisCell ProliferationMutationHumansCell Line, TumorGene Expression Regulation, NeoplasticSignal TransductionStilbenes

Stichwörter der Autor:innen

cancerchemosensibilizationmutant p53reactivationresveratrol

Substanzen

ResveratrolTumor Suppressor Protein p53TP53 protein, humanStilbenes

Autor:innen und Institutionen

  • Departamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico.
  • Subdirección de Investigación Básica, Instituto Nacional de Cancerología, Av. San Fernando No. 22, Sección XVI, Tlalpan, Mexico City 14080, Mexico.
  • Tecnológico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Calle del Puente #222, Col. San Bartolo el Chico, Tlalpan, Mexico City 14380, Mexico.

ORCID-Profile: Solangy Lizcano-Meneses, José Díaz-Chávez

Förderung

  • Consejo Nacional de Ciencia y Tecnología, Mexico
  • Consejo Nacional de Ciencia y Tecnología, México

Zitieren

APA

Acosta-Dent, A., García-Villa, E., Cotino-Nájera, S., Lizcano-Meneses, S., Lagunas-Rangel, F. A., Garrido-Guerrero, E., Díaz-Chávez, J., & Gariglio, P. (2026). Reactivation of P53 Antiproliferative and Pro-Apoptotic Pathways by Resveratrol in Mutant P53 Cancer Cell Lines. International Journal of Molecular Sciences, 27(10), 4481. https://doi.org/10.3390/ijms27104481

Vancouver

Acosta-Dent A, García-Villa E, Cotino-Nájera S, Lizcano-Meneses S, Lagunas-Rangel FA, Garrido-Guerrero E, et al. Reactivation of P53 Antiproliferative and Pro-Apoptotic Pathways by Resveratrol in Mutant P53 Cancer Cell Lines. International Journal of Molecular Sciences. 2026;27(10):4481. doi:10.3390/ijms27104481

BibTeX
@article{AcostaDent2026,
  author = {Acosta-Dent, Andrea and García-Villa, Enrique and Cotino-Nájera, Sandra and Lizcano-Meneses, Solangy and Lagunas-Rangel, Francisco Alejandro and Garrido-Guerrero, Efraín and Díaz-Chávez, José and Gariglio, Patricio},
  title = {Reactivation of P53 Antiproliferative and Pro-Apoptotic Pathways by Resveratrol in Mutant P53 Cancer Cell Lines},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {10},
  pages = {4481},
  doi = {10.3390/ijms27104481}
}
Kostenlos starten →